RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator.

Guo, Tao; You, Ke; Chen, Xi; Sun, Yuqi; Wu, Ying; Wu, Ping; Jiang, Yingying

Guo, Tao; You, Ke; Chen, Xi; Sun, Yuqi; Wu, Ying; Wu, Ping; Jiang, Yingying.

Afiliação

Guo T; Department of Pathophysiology, School of Basic Medical Sciences, Weifang Medical University, Weifang, 261053, China.
You K; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Chen X; School of Stomatology, Weifang Medical University, Weifang, 261053, China.
Sun Y; School of Clinical Medicine, Weifang Medical University, Weifang, 261031, China.
Wu Y; Liuzhou Key Laboratory of Infectious Disease Immunity Research, Guangxi Health Commission Key Laboratory of Clinical Biotechnology, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, 545006, China.
Wu P; Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510000, China.
Jiang Y; School of Stomatology, Weifang Medical University, Weifang, 261053, China. jiangyy@wfmc.edu.cn.

Cell Death Discov ; 8(1): 320, 2022 Jul 14.

Article em En | MEDLINE | ID: mdl-35831298

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cell Death Discov Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google